Announcements Trials

Browse Landscape

Phase

Status

Recruiting 14 Active not recruiting 5 Completed 3 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Cyclophosphamide 128 Cisplatin 119 Radiotherapy 111 pembrolizumab 110 Paclitaxel 96 Gemcitabine 96 Carboplatin 96 Nivolumab 76 Magnetic Resonance Spectroscopy 76 Bevacizumab 76 Fluorouracil 74 Dexamethasone 73 Radiosurgery 66 Docetaxel 59 Rituximab 58 Leucovorin 57 Oxaliplatin 55 Capecitabine 55 Doxorubicin 52 fludarabine 51 Biopsy 48 durvalumab 44 Cytarabine 44 Drug Therapy 43 Etoposide 42 fludarabine phosphate 40 Pemetrexed 40 Radiation 39 atezolizumab 36 Lenalidomide 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Interventional × patritumab deruxtecan × Clear all

NCT05620914 2025-06-15

PARAMETer

Duke University

Phase 2 Withdrawn

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡